Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dysregulated metabolic homeostasis as a unifying death mechanism underlying the diverse clinical manifestations of COVID-19: insights from a retrospective analysis of sequential blood variables.

Frontiers in medicine·2026

Same author

Prognosticating the outcome of intensive care in older patients-a narrative review.

Annals of intensive care·2024

Same author

Separating the Wheat from the Chaff.

The Israel Medical Association journal : IMAJ·2022

Same author

Developing and validating a machine learning prognostic model for alerting to imminent deterioration of hospitalized patients with COVID-19.

Scientific reports·2022

Same author

Mechanistically Coupled PK (MCPK) Model to Describe Enzyme Induction and Occupancy Dependent DDI of Dabrafenib Metabolism.

Pharmaceutics·2022

Same author

A New Method for Optimizing Sepsis Therapy by Nivolumab and Meropenem Combination: Importance of Early Intervention and CTL Reinvigoration Rate as a Response Marker.

Frontiers in immunology·2021

Search research articles

Related Experiment Video

Updated: Mar 15, 2026

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Employing dynamical computational models for personalizing cancer immunotherapy.

Zvia Agur¹, Karin Halevi-Tobias¹, Yuri Kogan¹

¹a Institute for Medical BioMathematics (IMBM) , Bene Ataroth , Israel.

Expert Opinion on Biological Therapy

|August 27, 2016

Summary

Personalized mathematical models can predict cancer immunotherapy outcomes, improving treatment efficacy. Tailoring regimens to individual patients offers a promising approach beyond current clinical trial designs.

Keywords:

Mathematical model adoptive cell transfer cancer vaccination immune checkpoint inhibitor immunotherapy personalization model validation

More Related Videos

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

Related Experiment Videos

Last Updated: Mar 15, 2026

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

Area of Science:

Oncology
Immunology
Mathematical Biology

Background:

Cancer immunotherapy has shown success, but patient outcomes vary due to complex immune-cancer interactions.
Personalized prediction of therapy outcomes is needed to overcome variability.
Integrating patient data with dynamical mathematical models offers a potential solution.

Purpose of the Study:

To review the role of mathematical modeling in cancer immunotherapy.
To examine the feasibility of using these models for immunotherapy personalization.
To explore the potential of personalized mathematical models in improving treatment outcomes.

Main Methods:

Review of existing studies on mathematical modeling in cancer immunotherapy.
Analysis of the application of personalized mathematical models for treatment regimen development.
Assessment of the early construction and validation of personalized models.

Main Results:

Mathematical models can be used to develop patient-specific immunotherapy regimens.
Personalized models can be constructed and validated early in the treatment process.
These models show potential for improving immunotherapy response.

Conclusions:

Personalized mathematical modeling can enhance overall immunotherapy efficacy.
Early implementation during drug development may improve clinical approval prospects.
Adjusting clinical trial paradigms to include personalized regimens is recommended.